首页> 外文期刊>European journal of neurology: the official journal of the European Federation of Neurological Societies >Cross‐sectional and longitudinal associations between probable rapid eye movement sleep behavior disorder and impulse control disorders in Parkinson’s disease
【24h】

Cross‐sectional and longitudinal associations between probable rapid eye movement sleep behavior disorder and impulse control disorders in Parkinson’s disease

机译:在帕金森病中可能的快速眼球运动睡眠行为障碍和脉冲控制障碍之间的横截面和纵向关联

获取原文
获取原文并翻译 | 示例
       

摘要

Background and purpose The aim was to investigate whether probable rapid eye movement sleep behavior disorder (pRBD) is associated with impulse control disorders (ICDs) in drug‐na?ve patients with Parkinson’s disease (PD) and whether baseline pRBD is associated with a higher incidence of ICDs during follow‐up. Methods The Parkinson’s Progression Markers Initiative is an international, multicenter, prospective cohort study to identify biomarkers of PD progression. In all, 423 drug‐na?ve patients with early‐stage PD were included in the cross‐sectional analysis, and 320 patients who screened negative for any ICDs or related behaviors at baseline were included in the longitudinal analysis. Results In the cross‐sectional analysis, a significant correlation was found between pRBD and ICDs in drug‐na?ve patients whilst controlling for potential confounders [odds ratio 2.56, 95% confidence interval (CI)?1.38–4.76, P ?=?0.003]. In the longitudinal analysis, baseline pRBD was an independent predictor of ICD development over time [hazard ratio (HR) 1.648, 95% CI 1.054–2.576; P ?=?0.028]. Other significant predictors of ICDs included younger age of onset (HR?=?0.973, 95% CI?=?0.950–0.997; P ?=?0.026) and greater State‐Trait Anxiety Inventory score (HR?=?1.040, 95% CI?=?1.020–1.061; P ??0.001). Conclusion Our data suggest that identifying baseline pRBD in early‐stage PD may help clinicians to choose a better therapeutic strategy so as to prevent or limit neuropsychiatric complications.
机译:背景和目的目的是调查可能的快速眼睛运动睡眠行为障碍(PRBD)是否与帕金森病(PD)患者的脉冲控制障碍(ICDS)有关,以及基线PRBD是否与更高相关的在随访期间ICD的发病率。方法帕金森的进展标志倡议是一个国际,多中心,前瞻性队列研究,以识别PD进展的生物标志物。总而言之,423名药物-NAα患者患有早期PD的患者含有早期PD的横截面分析,并在纵向分析中包括320名筛选任何ICDS或相关行为的阴性患者。结果在横截面分析中,在药物-NA'VE患者中PRBD和ICDS之间发现了显着的相关性,同时控制潜在混淆[赔率比2.56,95%置信区间(CI)?1.38-4.76,P?=? 0.003]。在纵向分析中,基线PRBD是ICD开发的独立预测因素,随着时间的推移[危险比(HR)1.648,95%CI 1.054-2.576; p?= 0.028]。 ICD的其他显着预测因子包括年轻的发病年龄(HR?= 0.973,95%CI?=?0.950-0.997; p?= 0.026)和更大的国家特质焦虑库存得分(HR?=?1.040,95% CI?=α= 1.020-1.061; p?<0.001)。结论我们的数据表明,在早期PD中识别基线PRBD可能有助于临床医生选择更好的治疗策略,以防止或限制神经精神复杂性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号